TW201728B - - Google Patents

Download PDF

Info

Publication number
TW201728B
TW201728B TW79100738A TW79100738A TW201728B TW 201728 B TW201728 B TW 201728B TW 79100738 A TW79100738 A TW 79100738A TW 79100738 A TW79100738 A TW 79100738A TW 201728 B TW201728 B TW 201728B
Authority
TW
Taiwan
Prior art keywords
compound
item
patent application
water
mixture
Prior art date
Application number
TW79100738A
Other languages
English (en)
Chinese (zh)
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Application granted granted Critical
Publication of TW201728B publication Critical patent/TW201728B/zh

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
TW79100738A 1989-02-03 1990-02-02 TW201728B (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898902472A GB8902472D0 (en) 1989-02-03 1989-02-03 Anti-inflammatory aryl derivatives

Publications (1)

Publication Number Publication Date
TW201728B true TW201728B (no) 1993-03-11

Family

ID=10651104

Family Applications (1)

Application Number Title Priority Date Filing Date
TW79100738A TW201728B (no) 1989-02-03 1990-02-02

Country Status (6)

Country Link
DD (1) DD291756A5 (no)
GB (1) GB8902472D0 (no)
IE (1) IE900382L (no)
RU (1) RU2002738C1 (no)
TW (1) TW201728B (no)
ZA (1) ZA90808B (no)

Also Published As

Publication number Publication date
DD291756A5 (de) 1991-07-11
GB8902472D0 (en) 1989-03-22
IE900382L (en) 1990-08-03
ZA90808B (en) 1991-10-30
RU2002738C1 (ru) 1993-11-15

Similar Documents

Publication Publication Date Title
JP7066768B2 (ja) 細胞内カルシウムを調節する化合物
KR101724161B1 (ko) 세포내 칼슘을 조절하는 화합물
JP6807841B2 (ja) エストロゲン受容体モジュレーター及びその使用
CN110177554B (zh) 用于治疗癌症的组合疗法
TW313567B (no)
RU2465272C2 (ru) Соединения, моделирующие внутриклеточный кальций
CN102018698B (zh) 治疗雌激素受体相关疾病的化合物及其方法
CA2917742C (en) A pharmaceutical combination for the treatment of melanoma
TWI226829B (en) Pharmaceutical compositions for treatment of partial responders or refractory depression
EP0384594B1 (en) Anti-inflammatory aryl derivatives
KR20170113546A (ko) 옥사티아진-유사 화합물의 제조방법
HUE027577T2 (en) Use of morpholinylbenzotriazole in cancer therapy
CN104394855A (zh) 用于测定肝细胞癌(hcc)患者的治疗的有效响应的生物标记
JP2021530486A (ja) 選択的エストロゲン受容体分解剤
JP2021529757A (ja) 小胞体ストレス応答の活性剤
CN103502219A (zh) 作为治疗剂的新型小分子
WO2017079566A1 (en) Caspase inhibitors for use in the treatment of liver cancer
EP2474528A1 (en) Antineoplasic compounds and pharmaceutical compositions thereof
CN105189469B (zh) 2-氨基-3,4-二氢喹唑啉衍生物及其作为组织蛋白酶d抑制剂的用途
TW201728B (no)
JP2000512272A (ja) 酸化窒素の合成を増大させる方法
CN111821303B (zh) 沃替西汀及其盐在制备抗肿瘤药物中的应用
CN108473504A (zh) 新型二氢吡喃并嘧啶酮衍生物及其用途
US10064843B2 (en) Bis-amide derivative and use thereof
JP2016540044A (ja) 新規な抗ｈｐｖ医薬製剤の用途